Pages that link to "Q31080677"
Jump to navigation
Jump to search
The following pages link to Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming (Q31080677):
Displaying 50 items.
- Application of population pharmacokinetics to cladribine (Q24794793) (← links)
- Population pharmacokinetics of bevacizumab in cancer patients with external validation (Q26779580) (← links)
- Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure (Q28306178) (← links)
- Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparum (Q28534820) (← links)
- Ozanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsies (Q28543591) (← links)
- Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales (Q30497328) (← links)
- Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models (Q30499990) (← links)
- Comparisons of Analysis Methods for Proof-of-Concept Trials. (Q30537763) (← links)
- A model-based approach to predict longitudinal HbA1c, using early phase glucose data from type 2 diabetes mellitus patients after anti-diabetic treatment. (Q30619387) (← links)
- Comparison of methods for handling missing covariate data (Q30666096) (← links)
- First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole (Q30844731) (← links)
- Osteoarthritis disease progression model using six year follow-up data from the osteoarthritis initiative (Q30850701) (← links)
- Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria. (Q30867699) (← links)
- A longitudinal model for non-monotonic clinical assessment scale data (Q31018226) (← links)
- Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions. (Q31020563) (← links)
- Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations (Q31097010) (← links)
- Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia (Q31103489) (← links)
- Non-Bayesian knowledge propagation using model-based analysis of data from multiple clinical studies (Q31135720) (← links)
- Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine. (Q31138033) (← links)
- Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis. (Q31153944) (← links)
- Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968). (Q33419744) (← links)
- Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients (Q33432698) (← links)
- Handling data below the limit of quantification in mixed effect models (Q33447430) (← links)
- Evaluation of the nonparametric estimation method in NONMEM VI: application to real data (Q33477451) (← links)
- Quantitative pharmacology approach in Alzheimer's disease: efficacy modeling of early clinical data to predict clinical outcome of tesofensine (Q33524423) (← links)
- Translational pharmacokinetic-pharmacodynamic modelling; application to cardiovascular safety data for PF-00821385, a novel HIV agent (Q33560293) (← links)
- Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine (Q33601831) (← links)
- Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria (Q33622892) (← links)
- Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer (Q33795052) (← links)
- Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease (Q33797950) (← links)
- IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach (Q33840340) (← links)
- Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles (Q33882905) (← links)
- Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine (Q34000752) (← links)
- Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation (Q34046207) (← links)
- Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics (Q34149022) (← links)
- Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti -tuberculosis therapy (Q34235116) (← links)
- Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance (Q34309475) (← links)
- Population pharmacokinetics of blonanserin in Chinese healthy volunteers and the effect of the food intake (Q34328266) (← links)
- Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda (Q34331026) (← links)
- The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects (Q34486811) (← links)
- Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation (Q34545217) (← links)
- Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period (Q34570937) (← links)
- Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen (Q34571065) (← links)
- Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. (Q34596303) (← links)
- Population pharmacokinetics of deferiprone in healthy subjects (Q34635568) (← links)
- Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder. (Q34700914) (← links)
- Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model (Q34737629) (← links)
- Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals (Q34975110) (← links)
- Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria (Q34993096) (← links)
- A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients (Q35080129) (← links)